Dendritic cell immunotherapy for HIV infection: from theory to reality.

about

An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie

P2860

Q30407263-AA3A149B-62B0-420F-B358-66920A0FB021 Q39201703-4CF6213F-32B0-4049-9F64-13B4A8984635

P2860

Dendritic cell immunotherapy for HIV infection: from theory to reality.

Item

http://www.wikidata.org/entity/Q37773251

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@en

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@nl

type

Item

label

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@en

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@nl

prefLabel

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@en

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@nl

P1476

Dendritic cell immunotherapy for HIV infection: from theory to reality.

@en

P2093

Alberto José da Silva Duarte

http://www.w3.org/2001/XMLSchema#string

Alexandre de Almeida

http://www.w3.org/2001/XMLSchema#string

Telma Miyuki Oshiro

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

Dendritic cells and the control of immunity

Timing the ancestor of the HIV-1 pandemic strains

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Toll-like receptor control of the adaptive immune responses

Toll-like receptors and innate immunity

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

P304

1039-1051

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.09.68

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20635918

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Dendritic cell immunotherapy for HIV infection: from theory to reality.

about

P2860

P2860

Dendritic cell immunotherapy for HIV infection: from theory to reality.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921